Medtelligence is dedicated to the creation of innovative, continuing medical education (CME) focusing on cardiovascular and cardiometabolic disease. Through the use of comprehensive, strategically aligned curricula, Medtelligence facilitates the sharing of research, knowledge, and clinical practice skills to engage medical practitioners to fulfill their commitment to lifelong professional development and ultimately improved patient care.
Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction
Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction
Nonsteroidal MRAs: Latest Evidence of Cardiorenal Protection in CKD and T2D
Nonsteroidal MRAs: Latest Evidence of Cardiorenal Protection in CKD and T2D
Adopting the New Therapeutic “Lineup” to Manage ASCVD - East
Adopting the New Therapeutic “Lineup” to Manage ASCVD - East
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
High-Risk HFrEF: Who Will Benefit Most from Novel Therapies?
High-Risk HFrEF: Who Will Benefit Most from Novel Therapies?
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction
Clinicians' Update on Omega-3s in ASCVD Risk Reduction
Clinicians' Update on Omega-3s in ASCVD Risk Reduction
A Closer Look at Women, Atherosclerosis, and Lipids: What Is Different?
A Closer Look at Women, Atherosclerosis, and Lipids: What Is Different?
Variable Effects of Omega-3 Fatty Acids for ASCVD Event Reduction: Why?
Variable Effects of Omega-3 Fatty Acids for ASCVD Event Reduction: Why?
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness
Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness